Generated by GPT-5-mini| House of Lords Science and Technology Committee | |
|---|---|
| Name | House of Lords Science and Technology Committee |
| Chamber | House of Lords |
| Legislature | Parliament of the United Kingdom |
| Founded | 2000 |
| Jurisdiction | United Kingdom |
| Chair | Lord Patel of Bradford |
| Website | Commons and Lords Select Committees |
House of Lords Science and Technology Committee
The House of Lords Science and Technology Committee is a select committee of the House of Lords of the Parliament of the United Kingdom that examines scientific and technological issues, scrutinises policy, and produces reports to inform debates in the House of Lords and influence action by the United Kingdom Government. Its work intersects with devolved institutions such as the Scottish Parliament, Senedd Cymru, and bodies including the National Health Service (England), UK Research and Innovation, Medical Research Council, and the Engineering and Physical Sciences Research Council.
Established in the early 21st century, the committee was formed amid contemporaneous inquiries by the House of Commons Science and Technology Committee, the Royal Society, and the Wellcome Trust into the governance of scientific advice and innovation. Its remit encompasses scrutiny of scientific evidence provided to ministers, examination of long-term strategic issues such as climate change, artificial intelligence, biotechnology, energy, and aspects of public health that touch on bodies like the Department of Health and Social Care and the Department for Business, Energy and Industrial Strategy. The committee has defined scope to call for papers, take oral evidence from witnesses drawn from institutions like University of Oxford, University of Cambridge, Imperial College London, University College London, and international organisations including the World Health Organization and the European Commission.
Members are peers drawn from parties represented in the House of Lords and independent crossbenchers, including notable figures from academia, industry, and civil service such as former chairs who were peers with backgrounds linked to Imperial College London, King's College London, University of Edinburgh, University of Manchester, and London School of Economics. The committee has included members associated with institutions like the Royal Society, the Royal Academy of Engineering, the British Medical Association, and the Institute of Physics. Leadership has alternated between life peers and crossbench peers; chairs have engaged with ministers from departments including the Home Office, the Foreign, Commonwealth and Development Office, and the Treasury during evidence sessions. Membership turnover reflects appointments and retirements within the House of Lords and interactions with bodies such as the House of Commons select committees.
The committee conducts thematic inquiries producing reports that cite evidence from specialists at King's College London, University of Glasgow, University of Warwick, University of Birmingham, and think tanks like the Institute for Government, the RAND Corporation, and the Adam Smith Institute. Past inquiries have addressed genome editing, nuclear power and operators such as EDF Energy, fusion energy initiatives like ITER, artificial intelligence governance tied to actors such as DeepMind and OpenAI, and pandemics with witnesses from Public Health England, the NHS England, and the Wellcome Sanger Institute. Reports have recommended actions referencing legislation such as the Human Fertilisation and Embryology Act 1990 and institutions like the Health and Safety Executive, while engaging with international frameworks including the Paris Agreement and the International Health Regulations (2005). The committee's reports often prompt follow-up correspondence with ministers, evidence sessions with witnesses from Nesta, Biotechnology and Biological Sciences Research Council, Cancer Research UK, and oral hearings featuring representatives from companies like AstraZeneca and GlaxoSmithKline.
Committee reports have influenced policy debates in the House of Commons, prompted responses from Prime Minister's Office briefings, and elicited formal responses from departments including the Department for International Trade and the Department for Environment, Food and Rural Affairs. Recommendations have been taken up in White Papers, influenced funding decisions at UK Research and Innovation, and informed statutory reviews such as those led by the Competition and Markets Authority or the National Audit Office. The committee's work shaped parliamentary scrutiny during crises involving COVID-19 pandemic in the United Kingdom, energy security linked to North Sea oil and gas and Sizewell C, and regulatory approaches to technologies pioneered by Microsoft, Tesla, Inc., and Siemens. Government responses sometimes accept recommendations in full, partially implement measures, or publish rebuttals citing evidence from advisory bodies like the Scientific Advisory Group for Emergencies.
The committee is supported by a secretariat drawn from the House of Lords administration, staffed by clerks, researchers, and specialist advisers with links to academic networks at University of Sheffield, University of Leeds, and policy institutes including the Chatham House. Procedures mirror those of other select committees: issuing calls for evidence, publishing evidence papers, holding public oral evidence sessions in committee rooms in the Palace of Westminster, and producing reports laid before both Houses of Parliament of the United Kingdom. The secretariat liaises with external institutions such as the National Physical Laboratory, the Met Office, and the UK Space Agency to verify technical material, and collaborates with the House of Commons Library for research briefings. Transcripts and published evidence inform follow-up sessions and potential referrals to bodies like the Electoral Commission or the Information Commissioner's Office when inquiries touch on data, privacy, or governance issues.